Cargando…
Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit
BACKGROUND: Invasive pneumococcal disease (IPD) results in high morbidity and mortality globally each year, although it is a vaccine-preventable disease. This study aimed to characterize the clinical features of IPD in a pediatric intensive care unit (PICU) in Taiwan. The seven-valent pneumococcal c...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504450/ https://www.ncbi.nlm.nih.gov/pubmed/26184113 http://dx.doi.org/10.1186/s12887-015-0387-7 |
_version_ | 1782381459119538176 |
---|---|
author | Hsiao, Hsiang-Ju Wu, Chang-Teng Huang, Jing-Long Chiu, Cheng-Hsun Huang, Yhu-Chering Lin, Jainn-Jim Huang, I-Anne Chan, Oi-Wa Chou, I-Jun Hsia, Shao-Hsuan |
author_facet | Hsiao, Hsiang-Ju Wu, Chang-Teng Huang, Jing-Long Chiu, Cheng-Hsun Huang, Yhu-Chering Lin, Jainn-Jim Huang, I-Anne Chan, Oi-Wa Chou, I-Jun Hsia, Shao-Hsuan |
author_sort | Hsiao, Hsiang-Ju |
collection | PubMed |
description | BACKGROUND: Invasive pneumococcal disease (IPD) results in high morbidity and mortality globally each year, although it is a vaccine-preventable disease. This study aimed to characterize the clinical features of IPD in a pediatric intensive care unit (PICU) in Taiwan. The seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the private sector in October 2005. The estimated coverage rate of PCV7 vaccination in 2010 was 45.5 % among children <5 years of age. METHODS: We conducted a retrospective study at a single center in northern Taiwan for invasive pneumococcal disease in a PICU from 2009 to 2013. Demographic characteristics, clinical courses, serotype, antibiotic susceptibility, and outcomes were analyzed. RESULTS: Over the 5-year study period, 2167 patients were admitted to the PICU; 48 (2.2 %) had IPD. There were 29 female and 19 male patients. Their mean age was 3.7 years (range 0.7–12.5 years, with the peak age at 2–5 years; n = 30, 63 %). Pneumonia was the most frequent type (n = 38, 79 %), followed by meningitis (n = 10, 21 %). In total, three patients died, all within 72 h after admission; the final diagnoses were all meningitis. Thirty-four children with pneumonia received chest tube insertion for pleural effusion drainage. Of them, 22 (65 %) finally still underwent video-assisted thoracoscopic surgery. Eight (17 %) children had hemolytic uremic syndrome, and seven of them underwent hemodialysis. In total, 37 serotypes were detected; 95 % were covered by PCV13. Serotype 19A was most common (54 %) overall; however, in those with meningitis, serotype 19 F was most common. CONCLUSIONS: Meningitis is the most severe type of invasive pneumococcal disease in our pediatric intensive care unit. It may progress rapidly even when subjects are given antibiotics promptly. The most common serotype in meningitis is 19 F, which is vaccine preventable. Thus, universal mass pneumococcal vaccination is still needed. |
format | Online Article Text |
id | pubmed-4504450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45044502015-07-17 Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit Hsiao, Hsiang-Ju Wu, Chang-Teng Huang, Jing-Long Chiu, Cheng-Hsun Huang, Yhu-Chering Lin, Jainn-Jim Huang, I-Anne Chan, Oi-Wa Chou, I-Jun Hsia, Shao-Hsuan BMC Pediatr Research Article BACKGROUND: Invasive pneumococcal disease (IPD) results in high morbidity and mortality globally each year, although it is a vaccine-preventable disease. This study aimed to characterize the clinical features of IPD in a pediatric intensive care unit (PICU) in Taiwan. The seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the private sector in October 2005. The estimated coverage rate of PCV7 vaccination in 2010 was 45.5 % among children <5 years of age. METHODS: We conducted a retrospective study at a single center in northern Taiwan for invasive pneumococcal disease in a PICU from 2009 to 2013. Demographic characteristics, clinical courses, serotype, antibiotic susceptibility, and outcomes were analyzed. RESULTS: Over the 5-year study period, 2167 patients were admitted to the PICU; 48 (2.2 %) had IPD. There were 29 female and 19 male patients. Their mean age was 3.7 years (range 0.7–12.5 years, with the peak age at 2–5 years; n = 30, 63 %). Pneumonia was the most frequent type (n = 38, 79 %), followed by meningitis (n = 10, 21 %). In total, three patients died, all within 72 h after admission; the final diagnoses were all meningitis. Thirty-four children with pneumonia received chest tube insertion for pleural effusion drainage. Of them, 22 (65 %) finally still underwent video-assisted thoracoscopic surgery. Eight (17 %) children had hemolytic uremic syndrome, and seven of them underwent hemodialysis. In total, 37 serotypes were detected; 95 % were covered by PCV13. Serotype 19A was most common (54 %) overall; however, in those with meningitis, serotype 19 F was most common. CONCLUSIONS: Meningitis is the most severe type of invasive pneumococcal disease in our pediatric intensive care unit. It may progress rapidly even when subjects are given antibiotics promptly. The most common serotype in meningitis is 19 F, which is vaccine preventable. Thus, universal mass pneumococcal vaccination is still needed. BioMed Central 2015-07-17 /pmc/articles/PMC4504450/ /pubmed/26184113 http://dx.doi.org/10.1186/s12887-015-0387-7 Text en © Hsiao et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Hsiao, Hsiang-Ju Wu, Chang-Teng Huang, Jing-Long Chiu, Cheng-Hsun Huang, Yhu-Chering Lin, Jainn-Jim Huang, I-Anne Chan, Oi-Wa Chou, I-Jun Hsia, Shao-Hsuan Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit |
title | Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit |
title_full | Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit |
title_fullStr | Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit |
title_full_unstemmed | Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit |
title_short | Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit |
title_sort | clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504450/ https://www.ncbi.nlm.nih.gov/pubmed/26184113 http://dx.doi.org/10.1186/s12887-015-0387-7 |
work_keys_str_mv | AT hsiaohsiangju clinicalfeaturesandoutcomesofinvasivepneumococcaldiseaseinapediatricintensivecareunit AT wuchangteng clinicalfeaturesandoutcomesofinvasivepneumococcaldiseaseinapediatricintensivecareunit AT huangjinglong clinicalfeaturesandoutcomesofinvasivepneumococcaldiseaseinapediatricintensivecareunit AT chiuchenghsun clinicalfeaturesandoutcomesofinvasivepneumococcaldiseaseinapediatricintensivecareunit AT huangyhuchering clinicalfeaturesandoutcomesofinvasivepneumococcaldiseaseinapediatricintensivecareunit AT linjainnjim clinicalfeaturesandoutcomesofinvasivepneumococcaldiseaseinapediatricintensivecareunit AT huangianne clinicalfeaturesandoutcomesofinvasivepneumococcaldiseaseinapediatricintensivecareunit AT chanoiwa clinicalfeaturesandoutcomesofinvasivepneumococcaldiseaseinapediatricintensivecareunit AT chouijun clinicalfeaturesandoutcomesofinvasivepneumococcaldiseaseinapediatricintensivecareunit AT hsiashaohsuan clinicalfeaturesandoutcomesofinvasivepneumococcaldiseaseinapediatricintensivecareunit |